Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide studyJean‐Baptiste Bossard, Jean‐Baptiste Beuscart, Marie Robin et al.|American Journal of Hematology|2020Cited by 24
Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b StudyGuillermo Garcia‐Manero, Harinder Gill, Maximilian Stahl et al.|Blood|2024Cited by 9
Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation studyMarie Donzel, Vincent Alcazer, Syrine KHEDIMALLAH et al.|The Lancet Haematology|2026Cited by 1
Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study CovimLaurence Legros, Jean‐Jacques Kiladjian, Françoise Boyer perrard et al.|Blood|2022Cited by 0